Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Dhodapkar
Four Genes Predict High Risk of Progression From Smoldering to Symptomatic Multiple Myeloma (SWOG S0120)
Haematologica
Hematology
Related publications
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Hematology/Oncology Clinics of North America
Oncology
Hematology
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective
Oncologist
Cancer Research
Medicine
Oncology
Smoldering Multiple Myeloma: Prevalence and Current Evidence Guiding Treatment Decisions
Blood and Lymphatic Cancer: Targets and Therapy
Baseline Mutational Patterns and Sustained MRD Negativity in Patients With High-Risk Smoldering Myeloma
Blood advances
Hematology
High-Risk Multiple Myeloma: Different Definitions, Different Outcomes?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Extensive Bone Marrow Infiltration and Abnormal Free Light Chain Ratio Identifies Patients With Asymptomatic Myeloma at High Risk for Progression to Symptomatic Disease
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Phase II Trial of Pan-Kir2d Blockade With IPH2101 in Smoldering Multiple Myeloma
Haematologica
Hematology
